BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27671226)

  • 1. The critical role of mast cell-derived hypoxia-inducible factor-1α in regulating mast cell function.
    Liang X; Yin G; Ma Y; Xu K; Liu J; Li J
    J Pharm Pharmacol; 2016 Nov; 68(11):1409-1416. PubMed ID: 27671226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.
    Jeong HJ; Oh HA; Nam SY; Han NR; Kim YS; Kim JH; Lee SJ; Kim MH; Moon PD; Kim HM; Oh HA
    Int J Cancer; 2013 Jun; 132(11):2492-501. PubMed ID: 23161568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor-1 modulates upregulation of mutT homolog-1 in colorectal cancer.
    Qiu Y; Zheng H; Sun LH; Peng K; Xiao WD; Yang H
    World J Gastroenterol; 2015 Dec; 21(48):13447-56. PubMed ID: 26730155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α.
    Xiang J; Sun H; Su L; Liu L; Shan J; Shen J; Yang Z; Chen J; Zhong X; Ávila MA; Yan X; Liu C; Qian C
    Cancer Lett; 2017 Aug; 400():117-126. PubMed ID: 28478181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis.
    Zhang W; Tong D; Liu F; Li D; Li J; Cheng X; Wang Z
    Oncotarget; 2016 Feb; 7(5):5800-14. PubMed ID: 26735579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
    Zheng J; Sun X; Wang W; Lu S
    Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation.
    Fan Y; Potdar AA; Gong Y; Eswarappa SM; Donnola S; Lathia JD; Hambardzumyan D; Rich JN; Fox PL
    Nat Cell Biol; 2014 May; 16(5):445-56. PubMed ID: 24747440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ; Athanasou NA
    J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
    Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
    J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
    Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
    Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic and anti-proliferative effects of inhibition of HIF-1α by p-HIF-1α RNAi in colorectal cancer.
    Qiu YY; Hu SJ; Bao YJ; Liang B; Yan CN; Shi XJ; Yu H; Zou Y; Tang LR; Tang QF; Feng W; Yin PH
    Int J Clin Exp Pathol; 2015; 8(7):7913-20. PubMed ID: 26339356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell endogenous HIF-1α activity induces aberrant angiogenesis and interacts with TRAF6 pathway required for colorectal cancer development.
    Glaus Garzon JF; Pastrello C; Jurisica I; Hottiger MO; Wenger RH; Borsig L
    Neoplasia; 2020 Dec; 22(12):745-758. PubMed ID: 33142239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1α in colorectal carcinoma: review of the literature.
    Ioannou M; Paraskeva E; Baxevanidou K; Simos G; Papamichali R; Papacharalambous C; Samara M; Koukoulis G
    J BUON; 2015; 20(3):680-9. PubMed ID: 26214618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor-1alpha and -2alpha additively promote endothelial vasculogenic properties.
    Ben-Shoshan J; Maysel-Auslender S; Luboshits G; Barshack I; Polak-Charcon S; Tzahor E; Keren G; George J
    J Vasc Res; 2009; 46(4):299-310. PubMed ID: 19077391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and pathobiological implication of hypoxia-inducible factor-1alpha in human colorectal carcinoma].
    Fan LF; Diao LM; Jiang CQ; Tang ZJ; Xia D; Liu MQ; Liu ZS; Ai ZL
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):242-6. PubMed ID: 15256117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
    Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
    World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
    Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia.
    Kaidi A; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma].
    Zhou YL; Deng CS
    Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
    Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
    Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.